Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Open accessAbstract
The U.S. opioid epidemic is continuing, and drug overdose deaths nearly tripled during 1999-2014. Among 47,055 drug overdose deaths that occurred in 2014 in the United States, 28,647 (60.9%) involved an opioid (1). Illicit opioids are contributing to the increase in opioid overdose deaths (2,3). In an effort to target prevention strategies to address the rapidly changing epidemic, CDC examined overall drug overdose death rates during 2010-2015 and opioid overdose death rates during 2014-2015 by subcategories (natural/semisynthetic opioids, methadone, heroin, and synthetic opioids other than methadone).* Rates were stratified by demographics, region, and by 28 states with high quality reporting on death certificates of specific drugs involved in overdose deaths. During 2015, drug overdoses accounted for 52,404 U.S. deaths, including 33,091 (63.1%) that involved an opioid. There has been progress in preventing methadone deaths, and death rates declined by 9.1%. However, rates of deaths involving other opioids, specifically heroin and synthetic opioids other than methadone (likely driven primarily by illicitly manufactured fentanyl) (2,3), increased sharply overall and across many states. A multifaceted, collaborative public health and law enforcement approach is urgently needed. Response efforts include implementing the CDC Guideline for Prescribing Opioids for Chronic Pain (4), improving access to and use of prescription drug monitoring programs, enhancing naloxone distribution and other harm reduction approaches, increasing opioid use disorder treatment capacity, improving linkage into treatment, and supporting law enforcement strategies to reduce the illicit opioid supply.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Globally, opioid dependence contributed 9.2 million disability adjusted life years in 2010.
“In 2014, over 28 000 people in the USA died of opioid overdoses, translating to 76 deaths from opioids, or three deaths per hour; globally, opioid dependence contributed 9.2 million disability adjusted life years in 2010 [4,5].”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [4]
In 2014, over 28,000 people in the USA died of opioid overdoses, translating to 76 deaths from opioids, or three deaths per hour.
“In 2014, over 28 000 people in the USA died of opioid overdoses, translating to 76 deaths from opioids, or three deaths per hour; globally, opioid dependence contributed 9.2 million disability adjusted life years in 2010 [4,5].”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161 · see citing works
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697 · see citing works
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859 · see citing works
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1508490 · Cited by 1,044 · see citing works
Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.
Jones, C. M., Logan, J. E., Gladden, R. M., & Bohm, M. K. (2015) · PubMed Central · Cited by 476 · see citing works
Gladden, R. M., Martínez, P. D., & Seth, P. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533a2 · Cited by 426 · see citing works
Self-citationHaegerich, T. M., Paulozzi, L. J., Manns, B. J., & Jones, C. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.001 · Cited by 272 · see citing works
Dowell, D., Zhang, K., Noonan, R. K., & Hockenberry, J. M. (2016) · Health Affairs · doi:10.1377/hlthaff.2016.0448 · Cited by 264 · see citing works
Increases in Fentanyl-Related Overdose Deaths — Florida and Ohio, 2013–2015
Peterson, A. B., Gladden, R. M., Delcher, C., Spies, E., Garcia‐Williams, A. G., Wang, Y., Halpin, J., Zibbell, J. E., McCarty, C. L., DeFiore-Hyrmer, J., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533a3 · Cited by 188 · see citing works
Davis, G. G. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0323-x · Cited by 95 · see citing works
Jones, C. M., Baldwin, G. T., Manocchio, T., White, J. O., & Mack, K. A. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6526a2 · Cited by 74 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816 · see citing works
Vital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117 · see citing works
Sex and gender differences in substance use disorders
McHugh, R. K., Votaw, V. R., Sugarman, D. E., & Greenfield, S. F. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.10.012 · Cited by 1,076 · see citing works
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076 · see citing works
Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016.
Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a1 · Cited by 821 · see citing works
Self-citationStrang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639 · see citing works
Bias factor and therapeutic window correlate to predict safer opioid analgesics
Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell · doi:10.1016/j.cell.2017.10.035 · Cited by 567 · see citing works
Gummin, D. D., Mowry, J. B., Spyker, D. A., Brooks, D. E., Fraser, M. O., & Banner, W. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1388087 · Cited by 553 · see citing works
Risk Factors for Opioid-Use Disorder and Overdose
Webster, L. R. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002496 · Cited by 498 · see citing works
Drossman, D. A., Tack, J., Ford, A. C., Szigethy, E., Törnblom, H., & Van Oudenhove, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.279 · Cited by 470 · see citing works
Vivolo-Kantor, A. M., Seth, P., Gladden, R. M., Mattson, C. L., Baldwin, G. T., Kite-Powell, A., & Coletta, M. A. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6709e1 · Cited by 428 · see citing works
Self-citationFatal and nonfatal overdose among pregnant and postpartum women in Massachusetts
Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H., Bharel, M., Wilens, T. E., LaRochelle, M., Walley, A. Y., et al. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002734 · Cited by 327 · see citing works
Frank, J. W., Lovejoy, T. I., Becker, W. C., Morasco, B. J., Koenig, C. J., Hoffecker, L., Dischinger, H. R., Dobscha, S. K., & Krebs, E. E. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0598 · Cited by 318 · see citing works
The Opioid Epidemic: Crisis and Solutions
Skolnick, P. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052534 · Cited by 307 · see citing works
Designer drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262 · see citing works
Touchpoints—opportunities to predict and prevent opioid overdose: a cohort study.
Larochelle, M. R., Bernstein, R., Bernson, D., Land, T., Stopka, T. J., Rose, A. J., Bharel, M., Liebschutz, J. M., & Walley, A. Y. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.039 · Cited by 189 · see citing works
How good intentions contributed to bad outcomes: the opioid crisis
Rummans, T. A., Burton, M. C., & Dawson, N. L. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.12.020 · Cited by 174 · see citing works
Mindfulness-based interventions for chronic pain: evidence and applications
Majeed, M. H., Ali, A. A., & Sudak, D. M. (2018) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.11.025 · Cited by 173 · see citing works
Venkataramani, A. S., Bair, E. F., O’Brien, R. L., & Tsai, A. C. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.5686 · Cited by 168 · see citing works
Ketamine for the treatment of addiction: evidence and potential mechanisms
Ivan Ezquerra-Romano, I., Lawn, W., Krupitsky, E., & Morgan, C. J. A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.017 · Cited by 163 · see citing works
Hargraves, D., White, C., Frederick, R., Cinibulk, M., Peters, M., Young, A., & Elder, N. (2017) · Public Health Reviews · doi:10.1186/s40985-017-0077-0 · Cited by 161 · see citing works
Hernandez, I., He, M., Brooks, M. M., & Zhang, Y. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0919 · Cited by 161 · see citing works
Increased use of heroin as an initiating opioid of abuse
Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.05.030 · Cited by 153 · see citing works
Vigil, J. M., Stith, S. S., Adams, I. M., & Reeve, A. P. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187795 · Cited by 143 · see citing works
Zedler, B. K., Saunders, W. B., Joyce, A. R., Vick, C. C., & Murrelle, E. L. (2018) · Pain Medicine · doi:10.1093/pm/pnx009 · Cited by 119 · see citing works
Irvine, M. A., Oller, D., Boggis, J., Bishop, B., Coombs, D., Wheeler, E., Doe-Simkins, M., Walley, A. Y., Marshall, B. D. L., Bratberg, J., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00304-2 · Cited by 127 · see citing works
Addiction Biomarkers: Dimensional Approaches to Understanding Addiction
Kwako, L. E., Bickel, W. K., & Goldman, D. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.12.007 · Cited by 103 · see citing works
Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014.
Hirschtritt, M. E., Delucchi, K. L., & Olfson, M. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.12.010 · Cited by 93 · see citing works
Mobile applications for pain management: an app analysis for clinical usage
Zhao, P., Yoo, I., Lancey, R., & Varghese, E. (2019) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-019-0827-7 · Cited by 93 · see citing works
Baumann, M. H., Majumdar, S., Le Rouzic, V., Hunkele, A., Uprety, R., Huang, X. P., Xu, J., Roth, B. L., Pan, Y.-X., & Pasternak, G. W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.016 · Cited by 92 · see citing works
Changing Trends in Opioid Overdose Deaths and Prescription Opioid Receipt Among Veterans
Lin, L. (., Peltzman, T., McCarthy, J. F., Oliva, E. M., Trafton, J. A., & Bohnert, A. S. B. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.01.016 · Cited by 90 · see citing works
Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89 · see citing works
Preston, K. L., Kowalczyk, W. J., Phillips, K. A., Jobes, M. L., Vahabzadeh, M., Lin, J.-L., Mezghanni, M., & Epstein, D. H. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4966-9 · Cited by 77 · see citing works
Hassan, A. N., Le Foll, B., Imtiaz, S., & Rehm, J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.012 · Cited by 80 · see citing works
McCabe, S. E., Teter, C. J., Boyd, C. J., Wilens, T. E., & Schepis, T. S. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11958 · Cited by 79 · see citing works
A systematic review of opioid use after extremity trauma in orthopedic surgery
Koehler, R. M., Okoroafor, U. C., & Cannada, L. K. (2018) · Injury · doi:10.1016/j.injury.2018.04.003 · Cited by 70 · see citing works
Pauly, N. J., Slavova, S., Delcher, C., Freeman, P. R., & Talbert, J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.12.002 · Cited by 63 · see citing works
Goplerud, E., Hodge, S., & Benham, T. (2017) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0000000000001157 · Cited by 60 · see citing works
Campbell, C. I., Bahorik, A. L., VanVeldhuisen, P., Weisner, C., Rubinstein, A. L., & Ray, G. T. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.01.019 · Cited by 63 · see citing works
“In 2016, nearly half of all U.S. opioid overdose deaths involve a prescription opioid (Rudd et al., 2016a).”
BackgroundMarshall, J. R., Gassner, S. F., Anderson, C. L., Cooper, R. J., Lotfipour, S., & Chakravarthy, B. (2019) · Substance Abuse · doi:10.1080/08897077.2018.1442899 · Cited by 55 · see citing works
A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids
Moride, Y. (2019) · Pain Physician · doi:10.36076/ppj/2019.22.229 · Cited by 55 · see citing works
Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness
Owen-Smith, A., Stewart, C., Sesay, M. M., Strasser, S. M., Yarborough, B. J., Ahmedani, B., Miller-Matero, L. R., Waring, S. C., Haller, I. V., Waitzfelder, B. E., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-2456-1 · Cited by 54 · see citing works
McCabe, S. E., Wilens, T. E., Boyd, C. J., Chua, K.-P., Voepel-Lewis, T., & Schepis, T. S. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.11.010 · Cited by 51 · see citing works
Coffin, P. O., Santos, G.-M., Matheson, T., Behar, E., Rowe, C., Rubin, T., Silvis, J., & Vittinghoff, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183354 · Cited by 44 · see citing works
Addressing Adolescents’ and Young Adults’ Substance Use Disorders
Chadi, N., Bagley, S. M., & Hadland, S. E. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.015 · Cited by 44 · see citing works
A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health
Wiss, D. A. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00193 · Cited by 41 · see citing works
Beehler, G. P., Murphy, J. L., King, P. R., Dollar, K. M., Kearney, L. K., Haslam, A., Wade, M., & Goldstein, W. R. (2019) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000747 · Cited by 39 · see citing works
Ladapo, J. A., Larochelle, M. R., Chen, A., Villalon, M. M., Vassar, S., Huang, D. Y. C., & Mafi, J. N. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0544 · Cited by 38 · see citing works
Grigoras, C. A., Karanika, S., Velmahos, E., Alevizakos, M., Flokas, M.-E., Kaspiris-Rousellis, C., Evaggelidis, I.-N., Artelaris, P., Siettos, C. I., & Mylonakis, E. (2018) · Drugs · doi:10.1007/s40265-017-0846-6 · Cited by 37 · see citing works
The Toxicology Investigators Consortium Case Registry—the 2016 Experience
On behalf of the Toxicology Investigators Consortium Study Group, Farrugia, L. A., Rhyee, S. H., Calello, D. P., Campleman, S. L., Riederer, A. M., Malashock, H. R., Pizon, A., Wiegand, T., Wax, P. M., et al. (2017) · Journal of Medical Toxicology · doi:10.1007/s13181-017-0627-3 · Cited by 34 · see citing works
Burke, L. G., Zhou, X., Boyle, K. L., Orav, E. J., Bernson, D., Hood, M., Land, T., Bharel, M., & Frakt, A. B. (2020) · Addiction · doi:10.1111/add.14867 · Cited by 35 · see citing works
Bearnot, B., & Mitton, J. A. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000648 · Cited by 33 · see citing works
Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015
Rowe, C., Wheeler, E., Stephen Jones, T., Yeh, C., & Coffin, P. O. (2019) · Journal of Urban Health · doi:10.1007/s11524-018-0250-x · Cited by 28 · see citing works
Opioid tapering in patients with prescription opioid use disorder: A retrospective study
Zhou, K., Jia, P., Bhargava, S., Zhang, Y., Reza, T., Peng, Y. B., & Wang, G. G. (2017) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2017.09.005 · Cited by 18 · see citing works
Substance misuse-related poisoning deaths, England and Wales, 1993–2016
Handley, S., Ramsey, J., & Flanagan, R. (2018) · Drug Science, Policy and Law · doi:10.1177/2050324518767445 · Cited by 16 · see citing works
Paltzer, J., Moberg, D. P., Burns, M., & Brown, R. L. (2019) · Medical Care · doi:10.1097/mlr.0000000000001162 · Cited by 16 · see citing works
Nakamura, A., Yasufuku, K., Shimada, S., Aritomi, H., Furue, Y., Chiba, H., Muramoto, M., Takase, K., Koike, K., Matsumoto, T., et al. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135177 · Cited by 9 · see citing works
Dowdle, L. T., Borckardt, J. J., Back, S. E., Morgan, K., Adams, D., Madan, A., Balliet, W., & Hanlon, C. A. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.024 · Cited by 8 · see citing works
Breeden, M. A., Jacobs, C. K., Witthaus, M., Salas, J., Everard, K. M., Penton, E., & Scherrer, J. F. (2020) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2020.01.190247 · Cited by 8 · see citing works
Characteristics of patients with substance use disorder before and after the Affordable Care Act
Campbell, C. I., Parthasarathy, S., Altschuler, A., Young-Wolff, K. C., & Satre, D. D. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.028 · Cited by 7 · see citing works
- Authors
- Rudd, R. A., Seth, P., David, F., & Scholl, L.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2016-12-30
- Volume
- 65
- Issue
- 5051
- Pages
- 1445-1452
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W2561135550
- Cited by
- 2,194
- References
- 11
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 73 · 2023: 93 · 2022: 106 · 2021: 211 · 2020: 355 · 2019: 423 · 2018: 533 · 2017: 331 · 2016: 1 · 2013: 1 · 2012: 1
- FWCI
- 423.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- drug overdose deaths, opioid overdose deaths, opioid epidemic, heroin, synthetic opioids, illicitly manufactured fentanyl, methadone, opioid prescribing, prescription drug monitoring programs, naloxone, harm reduction, opioid use disorder treatment, law enforcement, United States
- MeSH terms
- Adolescent, Adult, Aged, Analgesics, Opioid, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, United States, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
